A case of eruptive pseudoangiomatosis: Clinical, histopathological, and dermoscopic findings

Kushwaha, Ramesh Kumar; Mohta, Alpana; Jain, Suresh

doi:10.4103/idoj.idoj_407_19

Cited by 3 publications

(3 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In the studied cases, 42.6% had symptoms of an upper respiratory infection, such as www.odermatol.com cough, fever, runny nose, sore throat, malaise, tiredness, and gastro-intestinal tract symptoms such as diarrhea in 4.3%. These were described in a study by Chaniotakis et al [8] and by most reports [1][2][3]5]. These features of prodromal symptoms may explain the suspected viral cause of the illness.…”

Section: Discussionmentioning

confidence: 86%

“…Eruptive pseudoangiomatosis (EPA) is a sudden-onset disease that affects children mainly [1]. Previously, a disease with an acute onset of reddish and blanchable papules associated with elevated body temperature was described in a number of children to resolve spontaneously; later on, the same disease was observed in adults [2].…”

Section: Introductionmentioning

confidence: 99%

“…Clinically, the disorder is manifested as small papules surrounded by a pale halo mostly on the exposed surfaces of the body, yet the covered areas may also be affected [3]. On microscopical examination of the affected skin, there is no inflammation or increased number of blood vessels, thus it is known as pseudoangioma [1,4]. The illness resembles a common disease that occurs in Japan caused by an insect bite [5].…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Eruptive pseudoangiomatosis: An epidemiological and clinical study

Mancy¹,

Awad²,

Hafedh³

2023

Our Dermatol Online

View full text Add to dashboard Cite

Background: Eruptive pseudoangiomatosis is an acute-onset illness presenting with a characteristic rash mainly on the exposed parts of the body. It is mostly symptomless and resolves spontaneously without sequels. Numerous agents are suspected to trigger the disease. Materials and Methods: Forty-five patients affected with eruptive pseudoangiomatosis were examined at the Dermatology and Venereology Department of Al-Ramadi Teaching Hospital during the period from January 1, 2018, to January 1, 2020. History taking and physical examination in addition to laboratory investigations were done for all patients. Results: Forty-five patients, 27 females and 18 males, were examined. Their mean age was fifteen years and the female-to-male ratio was 1.5:1. The younger age group was the most involved and a family history was detected in 5%. Prodromal symptoms were found in 63.8% and pruritus was a complaint in 35.5% of the patients. The extremities and face were the most affected and the disease was more common during the spring season. Conclusion: Eruptive pseudoangiomatosis is a spontaneously-resolving illness without complications, yet one must be aware of it and keep it in mind when facing a viral rash to avoid unnecessary investigations and treatments and to provide reassurance to the patient and their family. Key words: angioma; pseudoangioma; viral infection; pruritus; URTI

show abstract

Section: Discussionmentioning

confidence: 86%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Eruptive pseudoangiomatosis: An epidemiological and clinical study

Mancy¹,

Awad²,

Hafedh³

2023

Our Dermatol Online

View full text Add to dashboard Cite

show abstract

Eruptive pseudoangiomatosis and SARS‐CoV‐2 (COVID‐19) infection

Caldarelli¹,

Barba²,

Hurtado³

2021

Int J Dermatology

View full text Add to dashboard Cite

An Observational Study of Mucocutaneous Manifestations among SARS-CoV-2 Patients from Three COVID-19 Dedicated Tertiary Care Centers

Mohta

Nai

et al. 2021

Indian Dermatology Online Journal

Self Cite

View full text Add to dashboard Cite

Introduction: Ever since the outbreak of COVID-19, the respiratory system has been the chief focus of researches, however, understanding the impact of this disease on the integumentary system is just as essential. Objectives: We aimed at collecting data on any cutaneous manifestation arising in patients with active and recovering COVID-19 infection, or a direct consequence of the infection's treatment, and correlating these findings with systemic disease severity and duration. Materials and Methods: A prospective observational study was conducted in three tertiary care centers from Rajasthan, India, to acquire data of laboratory-confirmed cases of COVID-19 presenting with any mucocutaneous manifestation. Results: Eight predominant patterns of dermatological involvement were seen, namely, maculopapular (14.59%), urticarial (13.17%), perniotic (12.1%), pityriasis rosea (11.74%), acral erythema/edema (10.3%), petechial (4.63%), vesicular (2.49%), and livedo (1.78%). Rare findings included eruptive pseudoangioma, eruptive hypomelanosis, alopecia parvimaculata, geographic tongue, chikungunya-like hyperpigmentation, and nail changes. On correlating these findings with the gradient of the disease, livedo, vasculitis, exfoliation, and erythroderma were associated with severe disease, whereas perniosis and eruptive pseudoangioma were seen in mild illness. Conclusion: We reported a few previously unpublished skin manifestations of COVID-19, namely, geographic tongue, chikungunya-like pigmentation, eruptive hypomelanosis, and alopecia parvimaculata. This study provides a visual description of the muco-cutaneous manifestations of COVID-19 disease which could aid a dermatologist or physician in early diagnosis of this novel infection, especially in a resource-poor setting.

show abstract

A case of eruptive pseudoangiomatosis: Clinical, histopathological, and dermoscopic findings

Cited by 3 publications

References 6 publications

Eruptive pseudoangiomatosis: An epidemiological and clinical study

Eruptive pseudoangiomatosis: An epidemiological and clinical study

Eruptive pseudoangiomatosis and SARS‐CoV‐2 (COVID‐19) infection

An Observational Study of Mucocutaneous Manifestations among SARS-CoV-2 Patients from Three COVID-19 Dedicated Tertiary Care Centers

Contact Info

Product

Resources

About